Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

eg solutions Chief trades in 1.21m shares

Wed, 02nd Jul 2014 16:11

Elizabeth Gooch, the acting Chief Executive Officer of eg solutions has traded in a total of 1.21m shares at 52p each, the software company said on Wednesday. Of these, 120,000 were acquired by the company's former Chairman, Rodney Baker-Bates, and a further 60,000 by Mark Brady, a non-executive director. Following the £629.200 transaction, Gooch now holds 5.3m shares, equal to 32.2% of the issued share capital of the AIM-listed firm. The disposal comes one month after the group posted an upbeat trading statement, in which it said it expected revenues for the first half of the year to be ahead of the same period the prior year, and that its financial performance for the full year will be ahead of its own expectations. Top Director BuysGlaxoSmithKline (GSK) Director name: Sir Sir Christopher GentAmount purchased: 3,989 @ 1,564.00p Value: £62,388GlaxoSmithKline (GSK) Director name: Sir Sir Deryck MaughanAmount purchased: 2,189 @ 1,567.92p Value: £34,322GlaxoSmithKline (GSK) Director name: Dr Daniel (Dan) PodolskyAmount purchased: 1,641 @ 1,567.92p Value: £25,730Development Securities (DSC) Director name: Mr Barry BennettAmount purchased: 15,000 @ 215.55p Value: £32,332GlaxoSmithKline (GSK) Director name: Ms Lynn ElsenhansAmount purchased: 1,155 @ 1,567.92p Value: £18,109GlaxoSmithKline (GSK) Director name: Mr Dr Stephanie BurnsAmount purchased: 868 @ 1,567.92p Value: £13,610GlaxoSmithKline (GSK) Director name: Ms Judy LewentAmount purchased: 736 @ 1,567.92p Value: £11,540European Investment Trust (EUT) Director name: Dr. Michael WoodwardAmount purchased: 1,911 @ 779.97p Value: £14,905GlaxoSmithKline (GSK) Director name: Ms Jing UlrichAmount purchased: 547 @ 1,567.92p Value: £8,577Top Director SellsLiontrust Asset Management (LIO) Director name: Mr John Stephen IonsAmount sold: 900,000 @ 240.00p Value: £2,160,000Liontrust Asset Management (LIO) Director name: Mr Adrian John Reginald CollinsAmount sold: 500,000 @ 240.00p Value: £1,200,000EG Solutions (EGS) Director name: Ms Elizabeth GoochAmount sold: 1,210,000 @ 52.00p Value: £629,200Liontrust Asset Management (LIO) Director name: Mr Vinay Kumar AbrolAmount sold: 100,000 @ 240.00p Value: £240,000Vectura Group (VEC) Director name: Mr John R. BrownAmount sold: 159,100 @ 133.00p Value: £211,603Stagecoach Group (SGC) Director name: Mr Brian SouterAmount sold: 54,758 @ 376.70p Value: £206,273Vectura Group (VEC) Director name: Dr Trevor PhillipsAmount sold: 109,500 @ 133.00p Value: £145,635Stagecoach Group (SGC) Director name: Mr Martin GriffithsAmount sold: 34,437 @ 376.70p Value: £129,724Stagecoach Group (SGC) Director name: Mr Ross PatersonAmount sold: 12,760 @ 376.70p Value: £48,067British Assets Trust (BSET) Director name: Miss Lynn RuddickAmount sold: 11,180 @ 135.50p Value: £15,149NR
More News
9 Jul 2021 07:31

UPDATE 2-Marlboro maker Philip Morris to buy UK drugmaker in 'beyond nicotine' push

* Vectura withdraws support for Carlyle deal* UK firm recommends Philip Morris offer* Deal is second by Philip Morris in a week* Shares jump nearly 13% (Recasts, adds detail, background)July 9 (Reuters) - Marlboro cigarettes maker Philip Morris Int...

Read more
9 Jul 2021 07:02

Philip Morris swoops for Vectura Group with £1bn bid

(Sharecast News) - Tobacco giant Philip Morris on Friday swooped for UK pharmaceuticals company Vectura Group with a £1.045bn recommended offer.

Read more
5 Jul 2021 15:23

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
18 Jun 2021 13:01

Vectura sets meeting date for GBP958 million takeover by Carlyle

Vectura sets meeting date for GBP958 million takeover by Carlyle

Read more
10 Jun 2021 10:35

Vectura completes management buy-out of Skyepharma Production unit

Vectura completes management buy-out of Skyepharma Production unit

Read more
4 Jun 2021 15:56

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
27 May 2021 17:27

EXECUTIVE CHANGES: Vectura senior director departs amid takeover offer

EXECUTIVE CHANGES: Vectura senior director departs amid takeover offer

Read more
27 May 2021 09:32

BROKER RATINGS: Barclays raises Aveva; HSBC says Buy Severn Trent

BROKER RATINGS: Barclays raises Aveva; HSBC says Buy Severn Trent

Read more
27 May 2021 08:45

LONDON MARKET OPEN: Stocks muted but more M&A spark in London

LONDON MARKET OPEN: Stocks muted but more M&A spark in London

Read more
27 May 2021 07:56

LONDON MARKET PRE-OPEN: Aviva in strong quarter; Equiniti backs bid

LONDON MARKET PRE-OPEN: Aviva in strong quarter; Equiniti backs bid

Read more
26 May 2021 17:10

LONDON MARKET CLOSE: Stocks mixed; Vectura surges on takeover

LONDON MARKET CLOSE: Stocks mixed; Vectura surges on takeover

Read more
26 May 2021 13:43

LIVE MARKETS-UK travel reopening kick-starts airlines

* European STOXX index flat* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomson...

Read more
26 May 2021 12:45

LIVE MARKETS-ECB: mini-tapering worries

* European Stoxx index down 0.1%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@th...

Read more
26 May 2021 12:05

LONDON MARKET MIDDAY: Lacklustre moves but FTSE 250 outperforms on M&A

LONDON MARKET MIDDAY: Lacklustre moves but FTSE 250 outperforms on M&A

Read more
26 May 2021 12:02

LIVE MARKETS-DIY hedging

* European shares erase gains* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thoms...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.